A discovery by Queensland scientists could be the key to stopping damage caused by uncontrolled inflammation in a range of common diseases including liver disease, Alzheimer’s and gout.
University of Queensland researchers have uncovered how an inflammation process automatically switches off in healthy cells, and are now investigating ways to stop it manually when it goes awry.
UQ’s Institute for Molecular Bioscience (IMB) researcher Associate Professor Kate Schroder said this inflammation pathway drove many different diseases.
“Now that we understand how this pathway naturally turns off in health, we can investigate why it doesn’t turn off in disease — so it’s very exciting,” Dr Schroder said.
Her work at IMB’s Centre for Inflammation and Disease Research focuses on inflammasomes, which are machine-like protein complexes at the heart of inflammation and disease.
“These complexes form when an infection, injury or other disturbance is detected by the immune system, and they send messages to immune cells to tell them to respond,” Dr Schroder said.
“If the disturbance can’t be cleared, such as in the case of amyloid plaques in Alzheimer’s, these molecular machines continue to fire, resulting in neurodegenerative damage from the sustained inflammation.”
Dr Schroder’s team, led by Dr Dave Boucher, discovered that inflammasomes normally work with an in-built timer switch, to ensure they only fire for a specific length of time once triggered.
“The inflammasome initiates the inflammation process by activating a protein that functions like a pair of scissors, and cuts itself and other proteins,” Dr Schroder said.
“What we’ve found is that after a period of time this protein cuts itself a second time to turn off the pathway, so if we can tweak this system we may be able to turn it off manually in disease.”
Dr Schroder’s laboratory has begun studying the inflammasome in fatty liver disease, a rapidly growing health issue due to the increasing global incidence of obesity and diabetes.
“In some patients with this condition the liver becomes increasingly fatty and inflamed, and this can lead to cirrhosis – which can require liver transplantation – or even liver cancer.”
Compounds to block inflammasome have been developed by IMB researchers including Dr Schroder, and are being commercialised by start-up drug development company Inflazome Ltd.
The research, published in the Journal of Experimental Medicine (DOI: 10.1084/jem.20172222), was supported by the Australian Research Council, and involved laboratories at IMB and the UQ School of Chemistry and Molecular Biosciences.
Imaging for the project was performed in the IMB Cancer Biology Imaging Facility, funded by the Australian Cancer Research Foundation.
Scientists discover off-switch for ‘molecular machine’ active in many diseases from The University of Queensland on Vimeo.
Additional video: inflammasome animation on YouTube.
Learn more: Scientists discover off-switch for ‘molecular machine’ active in many diseases
The Latest on: Uncontrolled inflammation
[google_news title=”” keyword=”uncontrolled inflammation” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Uncontrolled inflammation
- Four of the best superfoods to help reduce inflammationon May 1, 2024 at 5:58 am
Inflammation can have a negative effect on our health, contributing to heart disease, cancer, stroke and diabetes ...
- Scientists identify new brain circuit in mice that controls body's inflammatory reactionson April 30, 2024 at 5:00 pm
"This new discovery could provide an exciting therapeutic venue to control inflammation and immunity," said Charles S. Zuker, Ph.D., the study's senior author, a principal investigator at Columbia's ...
- Anti-Inflammatory Diet May Lead to 21% Lower Risk of Cognitive Impairment, According to New Studyon April 30, 2024 at 11:28 am
It ranges from mild cognitive impairment to life-altering forms of dementia, including Alzheimer’s disease, according to the Centers for Disease Control and Prevention (CDC). While many factors ...
- Is Ozempic the New Anti-Inflammatory Wonder Drug?on April 30, 2024 at 4:00 am
Some GLP-1s are now FDA approved for chronic weight management, including Wegovy (semaglutide) and Saxenda (liraglutide), while others like Ozempic (semaglutide) are approved for type 2 diabetes but ...
- Stem cells improve memory, reduce inflammation in Alzheimer's mouse brainson April 29, 2024 at 10:27 am
When people think of Alzheimer's Disease and possible treatment, amyloid—and the accumulation of plaques that invade the cerebral cortex—is often brought up first. However, scientists are finding that ...
- Glycogen Control Reviews - Does It Really Work?on April 29, 2024 at 5:45 am
Generally, the company advises taking one Glycogen Control pill a day. With a full glass of water or your favorite beverage, it is ideal to take the capsule. While you can take it whenever is most ...
- Glyco Clean Review (2024) Know ALL the Facts Before Buyon April 26, 2024 at 9:26 am
Some take green tea daily for weight loss. Others take it for blood sugar control, inflammation, and general health. According to some trials, green tea has been shown to impact glucose control ...
- Top 6 Best Joint Lubrication Supplements in 2024on April 24, 2024 at 5:00 pm
These supplements can potentially alleviate joint pain, control inflammation, increase flexibility and movement, and even enhance the general health of your joints. When it comes to choosing the ...
- Entyvio - Uses, Side Effects, and Moreon April 23, 2024 at 5:00 pm
This causes inflammation in the gut. Entyvio stops these white blood cells from getting into your gut, helping to control inflammation and prevent damage. How is Entyvio supplied (dosage forms)?
via Bing News